Colin Davidson is a neuropharmacologist and neurochemist. His main current interest is in drug abuse, and he has recently studied a number of legal highs. He is particularly interested in their pharmacology and their effects on transmitter release. Previously he has tested novel pharmacotherapies for stimulant abuse. He has also published in the field of Stroke where he has an interest in pre-ischaemic conditioning. His PhD was in the field of antidepressants and 5-HT efflux.
Colin is currently Head of School in the School of Pharmacy & Biomedical Sciences at the University of Central Lancashire. Previously Colin held faculty positions at St George's University of London, University of Leicester and Duke University Medical Centre. Colin has a BSc in Biology & Psychology from the University of Edinburgh, a PhD from Queen Mary's, University of London and was a postdoc at the University of St Andrews.